Regular ArticleReview of Immunological and Immunopathological Findings in Schizophrenia
References (194)
- et al.
T-cell subsets in acute psychotic schizophrenic patients
Biol. Psychiatry
(1994) Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
Schizophr. Res.
(1999)- et al.
Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients
Lancet
(1980) - et al.
Production of interferon-gamma in families with multiple occurrence of schizophrenia
Psychiatr. Res.
(1997) - et al.
Serum cytokine concentrations in patients with schizophrenia
Schizophr. Res.
(1996) - et al.
Evidence for activation of microglia in patients with psychiatric illnesses
Neurosci. Lett.
(1999) - et al.
Cytokine production in drug-free and neuroleptic-treated schizophrenic patients
Biol. Psychiatry
(1995) - et al.
Increased levels of CD8 + 45RA + lymphocytes in schizophrenic patients
Schizophr. Res.
(1998) - et al.
Cytokines production in chronic schizophrenia patients with or without paranoid behavior
Neuropsychopharmacol. Biol. Psychiatry
(1998) - et al.
Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients
Biol. Psychiatry
(1991)
Serum immunoglobulin levels in chinese male schizophrenics
Schizophr. Res.
(1993)
Are there antibodies against brain in sera from schizophrenic patient? Review and prospectus
Biol. Psychiatry
(1985)
Interleukin-1α and Interleukin-2 in cerebrospinal fluid of schizophrenic subjects
Proc. Neuropsychopharmacol. Biol. Psychiatry
(1993)
Altered interleukin-2 production in schizophrenia: Association between clinical state and autoantibody production
Psychiatry Res.
(1992)
Antinuclear and gastric parietal cell autoantibodies in schizophrenic patients
Biol. Psychiatry
(1992)
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Psychiatry Res.
(1994)
Abnormalities in serum concentrations of interleukin-2 interferon-α and interferon-γ in schizophrenia not detected
Schizophr. Res.
(1992)
Increased soluble interleukin 2 receptor levels in schizophrenia
Schizophr. Res.
(1998)
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis
J. Psychiatr. Res.
(1999)
Antiretroviral antibodies: Implications for schizophrenia, schizophrenia spectrum disorders and bipolar disorder
Biol. Psychiatry
(1999)
Antiseptal brain antibody in IgG of schizoprenic patients
Biol. Psychiatry
(1989)
Increased prevalence of antibrain antibodies in the sera from schizoprenic patients
Schizophr. Res.
(1994)
Monoclonal antibodies to study the brain in schizophrenia
Brain Res.
(1989)
Lymphokine produktion in leukocyte cultures of patients with schizophrenia
Schizophr. Res.
(1995)
From immoneurology to immunopsychiatry: Neuromodulating activity of anti-brain antibodies
Int. Rev. Neurobiol.
(1985)
Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia
Biol. Psychiatry
(1987)
Antibodies to the human 60 kDa heat-shock protein in patients with schizophrenia
Lancet
(1992)
Decreased Interleukin-2 production in Korean schizophrenic patients
Biol. Psychiatry
(1998)
Abnormal cerebrospinal fluid protein indices in schizophrenia
Biol. Psychiatry
(1985)
Increased serum neopterin levels in acutely ill and recovered schizophrenic patients
Schizophr. Res.
(1998)
Microglia: A sensor for pathological events in the CNS
Trends Neurosci.
(1996)
Cytokines and autoimmune disease
Clin. Immunol. Immunopathol.
(1991)
The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6
Schizophr. Res.
(1998)
Interleukin-2 and Interleukin-6 in schizophrenia and mania: Effects of Neuroleptica and mood stabilizers
J. Psychiatr. Res.
(1995)
Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs
Schizophr. Res.
(1996)
Lymphocyte subsets in schizophrenic disorders
Schizophr. Res.
(1990)
Antibodies to neuroblastoma cell line proteins in patients with schizophrenia
J. Neuroimmunol.
(1998)
Schizophrenic sera contain antibody against brain
J. Asthma Res.
(1967)
Cellular immunity and immune genetics in schizophrenia
Biol. Psychiatry
(1991)
Altered white cell count, protein concentration and olioclonal IgG bands in the cerebrospinal fluid of many patients with acute psychiatric disorders
Neuropsychobiology
(1985)
Immunoglobulins and Improvement in acute schizophrenic reactions
Arch. Gen. Psychiatry
(1973)
Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia
Acta Neuropathol.
(1996)
Recent advances in defining the neuropathology of schizophrenia
Acta Neuropathol.
(1996)
Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment
Mol. Psychiatry
(2000)
Changes in interleukin-1β and soluble Interleukin-2 receptor levels in CSF and serum of schizophrenic patients
J. Basic Clin. Physiol. Pharmacol.
(1995)
Tissuebinding factor in schizophrenic sera: A clinical and genetic study
Biol. Psychiatry
(1977)
Herpes simplex antibodies in the cerebrospinal fluid of schizophrenics patients
Acta Virol.
(1987)
Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the “Two hit hypothesis.”
J. Psychiatr. Res.
(1999)
Erweiterte kernspintomographische Untersuchungen bei Borna-disease-Virus-seropositiven psychiatrischen Patienten und Kontrollen
Nervenarzt
(1994)
Serum Interferon in first psychotic attack
Br. J. Psychiatry
(1990)
Cited by (161)
L-ficolin-MASP arm of the complement system in schizophrenia
2023, ImmunobiologyDeciphering microbiome and neuroactive immune gene interactions in schizophrenia
2020, Neurobiology of DiseaseAutoimmune phenotypes in schizophrenia reveal novel treatment targets
2018, Pharmacology and Therapeutics
Copyright © 2001 Elsevier Science (USA). All rights reserved.